Research confirms: concerns were justified
Today the results of the study into the consequences of switching from Thyrax to other brands of levothyroxine were published. Last year, 350.000 patients who used Thyrax were forced to switch to other brands of levothyroxine. The current study shows that the risk of an overdose after switching is high.
Please click here to read more (Dutch only)